PKvitality wins the EIT Health European Health Catapult semi-final

PKvitality has won the EIT Health European Health Catapult med-tech semi-final held at San Sebastian, Spain in early October 2019!

PKvitality is the only French start-up to reach the med-tech finals, which will take place in Paris in early December 2019.

By Prakhar, October 18, 2019

 

K’Watch invited again at VivaTech

We are pleased to have been invited by INPI and Orange to VivaTechnology salon from May 16th to 18th, 2019 at Paris Expo Porte de Versailles.

We will be present:
– On May 16th and 17th on the INPI booth in the Accelerate area in Hall 1 n°H47.
– On May 18th on the Orange booth in Hall 1 n°J09-158.

By Alice, May 13, 2019

 

PKvitality will be attending the MedTech and Biotech Showcases

The PKvitality team will be present at the MedTech and Biotech Showcases at San Francisco. Satellite event of the JP Morgan Healthcare Conference, the Biotech Showcase is a must-attend business convention in the field of biotechnology.

 

By Alice, January 07, 2019

 

K’Watch now a Continuous Glucose Monitor

K’Watch will be able to measure the glucose (and Lactate for the Athlete version in continuous mode). K’Watch can now be considered as a CGM (Continuous Glucose Monitoring) device.
This decision has been possible thanks to all the remarks you made, by email or while visiting our stands at CES, Vivatech or other tradeshows.

By Kévin, December 06, 2018

 

Pkvitality brought new progress at vivatech 2018

We are proud to have been invited again to participate in the Viva Technology Paris event, the largest technological startup show in european, in May 25, 26th 2018, at Porte de Versailles – Paris. Thanks to all of those who came to visit our booth, we were happy to share our updates with you, and with whom were curious about technologies that will change people’s life.

By Aimée, July 18, 2018

K’Watch Glucose wins Seal of Excellence from European Commision

We are excited to announce that PKvitality received Seal of Excellence from the European Commission H2020 instrument Phase 2. Following evaluation by an international panel of independent experts, K’Watch glucose is scored as a high-quality project proposal in a highly competitive evaluation process.

By Aimée, June 28, 2018

PKvitality prepares US market access

We are part of the 8 French Medtech companies selected to participate to the Soft Landing Boston 2018 program. Soft Landing Boston is a program dedicated to medtech and e-health companies (medical devices, connected objects and tools for diagnosis and monitoring).

By Hugo, March 5, 2018

PKvitality winner of the CIN (Digital Innovation Contest)

The K’Watch project is rewarded once again in the most beautiful way. We are indeed proud to be the winner of the Digital Innovation Contest (Concours Innovation Numérique or CIN in french) organized by the Public Investment Bank (BPIfrance).
BPIfrance funds us with more than 1M€, a mix of subsidy and loan. This will enable us to fund the development of the project in the coming months.

By Hugo, December 4, 2017

PKvitality closes its crowdfunding campaign

We have just closed our crowdfunding campaign for the K’Watch project on the SmartAngels platform.

Our crowdfunding campaign has finally ended after being extended for one and a half months due to an outpour of requests. We were more than glad to have extended the campaign to cater to more of you, and we are truly grateful to all those who participated.

By Hugo, September 12, 2017

PKvitality selected as one of 2 French medtechs in semi final of EIT Health Catapult contest

PKvitality is one of only two French MedTech companies selected for the european EIT Health Catapult competition. This contest is organized by the European Institute of Innovation and Technology , an independent EU body which dedicate to enhance Europe’s innovative competitiveness by supporting new ideas and nurturing entrepreneurial talent .

By Aimée, July 19, 2017

PKvitality wins H2020 “SME Instrument” Phase 1

We are pleased to announce that we are now an official laureate of the SME Instrument Phase 1 (Horizon 2020), which is the innovation and research program of the European Union. Endowed with 50,000 €, this program is one of the most selective and honors only less than 10% of the promising projects.

By Aimée, July 05, 2017

PKvitality invited by SANOFI at Vivatech

PKvitality is proud to have been selected by SANOFI to be present in their Lab during the Viva Technology fair from the 15th to the 17th of June 2017, in Paris, France. Head over to Sanofi booths C11-023 to meet our team and to learn more about K’Watch. We look forward to meeting you!

By Hugo, June 14, 2017

PKvitality at ATTD

Luck must have been on our side since the the beginning of the year, because as soon as the CES was over, we immediately extended the discussions on K’Watch through the Advanced Technologies & Treatments for Diabetes (ATTD) trade show. This took place from the 15th to the 18th of February in Paris, a stone’s throw away from our premises.

By Hugo, February 25, 2017

K’Watch fresh from the CES 2017

After garnering 3 Innovation Awards, K’Watch has been covered by international media .
In addition to coverage from the press, the K’Watch booth was also visited by more than a thousand people. In short, many rewarding contacts have validated that K’Watch adresses a real problem.

By Hugo, January 10, 2017

The K’Watch grabs 3 awards at CES

We had the honor of receiving 3 CES Innovation Awards.
The first in the category Fitness, Sports and Biotech; the second in the Wearable Technologies category. The third is the ultimate recognition — a BEST OF INNOVATION Award in the Tech for a Better World category.

By Hugo, January 3, 2017

PKvitality present at CES 2017

PKvitality will be at CES 2017 in Las Vegas to present K’Watch, the connected watch for diabetics.
We have chosen to present our PKvitality brand as well as K’Watch in the CES 2017 in Las Vegas. K’Watch is the first connected watch for diabetics.

By Hugo, January 1, 2017